September 17, 2009 — The US Food and Drug Administration (FDA)'s Arthritis Advisory Committee voted unanimously (12 to 0) yesterday to recommend approval of collagenase clostridium histolyticum ...

Compared with limited fasciectomy for Dupuytren contracture, injections of the enzyme collagenase are less costly but also less effective at straightening fingers. Nonetheless, patients may prefer the ...

Treatment options for Dupuytren’s contracture include limited fasciectomy and collagenase injection, but data comparing the two approaches are lacking. New research findings are summarized in a short ...

More than a decade after earning FDA approval for Xiaflex as a nonsurgical treatment option for Dupuytren’s contracture, Endo is debuting its first-ever branded TV commercial in the indication. In a ...

About Dupuytren's ContractureDC is a lifelong condition that may get worse over time. It's caused by a buildup of collagen in the hand, which forms a rope-like cord that pulls fingers toward the palm ...

Dupuytren contracture is a disorder that can cause the fingers to curl in, primarily the ring and small fingers. It's a genetic condition mostly affecting men over 60 of Northern European descent.

Campaign builds on the momentum of Endo's disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal ...

Xiaflex (collagenase clostridium histolyticum) is a brand-name injection that’s prescribed for Peyronie’s disease and Dupuytren’s contracture in adults. As with other drugs, Xiaflex can cause side ...

MALVERN, Pa., Feb. 17, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its new branded television commercial, Steve's Journey. The campaign, featuring a real Dupuytren's ...